 |
Presentations
2007
W Stokes, S Bremer, M Jacobs, A Ono, H Kojima, P Ceger, F Deal, R Tice.
NICEATM/ECVAM/JaCVAM multi-phased international validation study of an
in vitro estrogen receptor transcriptional activation assay to detect agonist and
antagonist activity. Sixth World Congress on Alternatives and Animal Use in the Life Sciences. View
Poster.
R Tice, F Deal, P Ceger, G Clark, J Gordon, W Stokes.
Standardization of protocols for the validation of an in vitro estrogen receptor
transcriptional activation assay. Sixth World Congress on Alternatives and Animal Use in the Life Sciences. View
Poster.
D Hattan, M Wind, P Ceger, F Deal, R Tice, W Stokes.
ICCVAM revised recommended substances for the validation of in vitro estrogen
receptor and androgen receptor binding and transcriptional activation test methods. Sixth World Congress
on Alternatives and Animal Use in the Life Sciences. View
Poster.
D Hattan, M Wind, F Deal, P Ceger, J Charles, R Tice, W Stokes.
ICCVAM revised recommended substance list for the evaluation of in vitro test methods for
identifying potential endocrine disruptors. Society of Toxicology 46th Annual Meeting. View
Poster.
W Stokes, S Bremer, M Jacobs, H. Kojima, P Ceger, F Deal, R. Tice.
Multi-phased international validation study of a stably-transfected estrogen receptor
(ER) transcriptional activation (TA) test method. Society of Toxicology 46th Annual Meeting. View Poster.
F Deal, P Ceger, G Clark, J Gordon, J Charles, R Tice, W Stokes.
Results of a protocol standardization study for the LUMI-CELL® estrogen receptor
(ER) transcriptional activation (TA) bioassay. Society of Toxicology 46th Annual Meeting. View Poster.
G Clark, J Gordon, M Denison, A Chu, M Chu, C Matherly, F Deal, P Ceger, J Charles, R Tice, W Stokes.
Comparison of visual inspection to CellTiter-Glo® in evaluating cytotoxicity in the LUMI-CELL® ER bioassay.
Society of Toxicology 46th Annual Meeting.
2005
B Blackard, C Inhof, R Tice, W Stokes, M Wind, D Hattan, L Schechtman.
ICCVAM recommended reference chemicals for validation of in vitro estrogen
and androgen receptor binding and transcriptional activation assays.
Fifth World Congress on Alternatives and Animal Use in the
Life Sciences. View Poster.
2003
B Shane, J Stegeman, E Wilson, C Inhof, R Tice, E Zeiger, W Stokes.
ICCVAM/NICEATM expert panel recommendations for the standardization and
validation of in vitro estrogen receptor (ER) and androgen receptor (AR)
transcriptional activation (TA) assays. Society of Toxicology 42nd Annual Meeting.
View Poster.
W Stokes, B Shane, C Inhof, R Tice, D Hatten, M Wind.
ICCVAM proposed substances for the validation of in vitro estrogen receptor (ER) and androgen receptor (AR)
transcriptional activation (TA) assays. Society of Toxicology 42nd Annual Meeting.
View Poster.
R Tice, G Daston, T Brown, B Shane, C Inhof, E Zeiger, W Stokes.
ICCVAM/NICEATM expert panel recommendations for the standardization and
validation of in vitro estrogen receptor (ER) and androgen receptor (AR)
binding assays. Society of Toxicology 42nd Annual Meeting.
2002
C Inhof, B Shane, E Zeiger, R Tice, W Stokes.
Candidate chemicals for validation of in vitro estrogen and androgen
receptor binding and transcriptional activation assays
Fourth World Congress on Alternatives and Animal Use in the
Life Sciences.
B Shane, C Inhof, E Zeiger, R Tice, W Stokes.
Comparative performance of estrogen receptor (ER) binding and transcriptional
activation assays for use as in vitro endocrine disruptor screening
methods, Fourth World Congress on
Alternatives and Animal Use in the Life Sciences.
|
